Enhanced antimyeloma cytotoxicity by the combination of arsenic trioxide and bortezomib is further potentiated by p38 MAPK inhibition.
Times cited: 36
P38 MAPK inhibition enhancing ATO-induced cytotoxicity against multiple myeloma cells.
British Journal of Haematology.
Times cited: 43